Arrowhead Initiates Project to Build New Manufacturing and Lab Facilities

SourceThe Joplin Globe
Date Published12/20/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Arrowhead Pharmaceuticals, Inc.
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):250
Year reshoring announced:2020
Year reshoring implemented or to be implemented:2023
Domestically, the work will be done:In-house
Capital investment ($):200
City reshored to:Verona
State(s) reshored to:WI
If relevant, work nearshored to:-
Product(s) reshoredRNAi medicines
What domestic positive factors made reshoring more attractive?Eco-system synergies
Find Reshoring Articles